AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8809929 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for 8 weeks)
Number of subjects: 106
Study 8809929 — intervention group
Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 106
Study 7941802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glucose 5% plus electrolytes, neostigmine, and dexpanthenon (Group A)
Number of subjects: 76
Study 7941802 — intervention group
Group type: COMPARATOR
Intervention: Standardized commercially available solutions without intravenous stimulation of the bowel (Group B)
Number of subjects: 76
Study 7941802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 76
Study 3124620 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air
Number of subjects: 12
Study 3124620 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 2% carbon dioxide
Number of subjects: 12
Study 3124620 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 4% carbon dioxide
Number of subjects: 12
Study 3124620 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled hyperventilation
Number of subjects: 12
Study 3124620 — intervention group
Group type: COMPARATOR
Intervention: Fetal gross body movements
Number of subjects: 12
Study 3124620 — intervention group
Group type: COMPARATOR
Intervention: Fetal heart rate
Number of subjects: 12
Study 3124620 — intervention group
Group type: COMPARATOR
Intervention: Fetal heart rate variability
Number of subjects: 12
Study 30961913 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvres with PEEP titration
Number of subjects: 1010
Study 28291976 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation group program
Number of subjects: 40
Study 28291976 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 40
Study 27789120 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 241
Study 27789120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study 22907789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour bolus flavor
Number of subjects: 51
Study 22907789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet bolus flavor
Number of subjects: 51
Study 22907789 — intervention group
Group type: EXPERIMENTAL
Intervention: Salty bolus flavor
Number of subjects: 51
Study 22907789 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no bolus flavor)
Number of subjects: 51
Study 21084654 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber rye bread (RB)
Number of subjects: 39
Study 21084654 — intervention group
Group type: COMPARATOR
Intervention: White-wheat bread (WB)
Number of subjects: 39
Study 19054526 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetuses of diabetic mothers
Number of subjects: 0
Study 19054526 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants of diabetic mothers (IDM)
Number of subjects: 0
Study 19054526 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal glycosylated hemoglobin
Number of subjects: 0
Study 17095972 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EA) with continuous infusion of fentanyl and bupivacaine for 2 days after VATS
Number of subjects: 46
Study 17095972 — intervention group
Group type: COMPARATOR
Intervention: No epidural analgesia (NEA)
Number of subjects: 46
Study 15005472 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using Fuji IX GP and Ketac‐Molar Aplicap in Class II cavities
Number of subjects: 60
Study 15005472 — intervention group
Group type: COMPARATOR
Intervention: Conventional cavity preparation using Fuji IX GP and Ketac‐Molar Aplicap in Class II cavities
Number of subjects: 60
Study 15005472 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using Fuji IX GP and Ketac‐Molar Aplicap in Class I cavities
Number of subjects: 60
Study 15005472 — intervention group
Group type: COMPARATOR
Intervention: Conventional cavity preparation using GK-amalgam in Class I cavities
Number of subjects: 60
Study 11354285 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated tegafur/uracil
Number of subjects: 56
Study 11354285 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 56
Study 8869333 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt-tipped needle
Number of subjects: 85
Study 8869333 — intervention group
Group type: COMPARATOR
Intervention: Cutting needle
Number of subjects: 85
Study 1671665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 250 mg/day
Number of subjects: 18
Study 1671665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 500 mg/day
Number of subjects: 18
Study 1671665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 750 mg/day
Number of subjects: 18
Study 6143335 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 6143335 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 30793924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nephrostomy tube (14F) removed 48 hours after surgery
Number of subjects: 60
Study 30793924 — intervention group
Group type: COMPARATOR
Intervention: Ureteral catheter (6F) removed at postoperative 12th hour
Number of subjects: 60
Study 29617922 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (single mass distribution)
Number of subjects: 21
Study 26399865 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IUs thrice weekly for 8 weeks and 50,000 IU every other week for 8 weeks)
Number of subjects: 199
Study 26399865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 23548455 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 35
Study 23548455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 20940005 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol detected in BAL for group I (induction)
Number of subjects: 45
Study 20940005 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol detected in BAL for group P (PEEP=10 cm H₂O)
Number of subjects: 45
Study 20940005 — intervention group
Group type: COMPARATOR
Intervention: Propofol detected in BAL for group Z (PEEP=0 cm H₂O)
Number of subjects: 45
Study 19586799 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin/Ezetimibe 40/10 mg daily
Number of subjects: 1873
Study 19586799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study 17561473 — intervention group
Group type: EXPERIMENTAL
Intervention: OMA orthopedic appliance
Number of subjects: 20
Study 17561473 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated Class III subjects)
Number of subjects: 20
Study 15152874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren twice a day for 10 days
Number of subjects: 45
Study 15152874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxim twice a day for 10 days
Number of subjects: 45
Study 11778092 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 45
Study 11778092 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 45
Study 11778092 — intervention group
Group type: COMPARATOR
Intervention: 0.5% ropivacaine
Number of subjects: 45
Study 9848851 — intervention group
Group type: EXPERIMENTAL
Intervention: N-methyl-D-aspartate receptor antagonist Selfotel
Number of subjects: 0
Study 9848851 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month Glasgow Outcome Scale scores
Number of subjects: 0
Study 8683947 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated Approach
Number of subjects: 600
Study 8683947 — intervention group
Group type: COMPARATOR
Intervention: Standard school health program
Number of subjects: 600
Study 2486382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 17
Study 2486382 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion
Number of subjects: 17
Study 2486382 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 17
Study 2486382 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety levels measured by panic description scale
Number of subjects: 17
Study 826945 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (0.7 mg of delta‐9‐tetrahydrocannabinol/kg)
Number of subjects: 12
Study 826945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 ml/kg)
Number of subjects: 12
Study 826945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30311692 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation technique (30 min at 20 Hz and 200 cycles/s, once a week for 12 weeks)
Number of subjects: 68
Study 30311692 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous therapy (PTNS) (30 min at 20 Hz and 200 cycles/s, once a week for 12 weeks)
Number of subjects: 68
Study 28846513 — intervention group
Group type: COMPARATOR
Intervention: MICT (Moderate-Intensity Continuous Training) - 30 min at 60%-70% HR peak/session, 150 min/week
Number of subjects: 99
Study 28846513 — intervention group
Group type: EXPERIMENTAL
Intervention: 4HIIT (High-Intensity Interval Training) - 4×4 min bouts at 85%-95% HR peak, interspersed with 3 min active recovery at 50%-70% HR peak, 114 min/week
Number of subjects: 99
Study 28846513 — intervention group
Group type: EXPERIMENTAL
Intervention: 1HIIT (High-Intensity Interval Training) - 1×4 min bout at 85%-95% HR peak, 51 min/week
Number of subjects: 99
Study 26115420 — intervention group
Group type: EXPERIMENTAL
Intervention: Doming of the diaphragm technique
Number of subjects: 60
Study 26115420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23774331 — intervention group
Group type: EXPERIMENTAL
Intervention: High E/Ea ratio
Number of subjects: 356
Study 21447261 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist splint
Number of subjects: 100
Study 21447261 — intervention group
Group type: COMPARATOR
Intervention: Cast
Number of subjects: 100
Study 19756416 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1500 mg/day) + omega-3 fatty acids (EPA and DHA)
Number of subjects: 177
Study 19756416 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine sulfate alone
Number of subjects: 177
Study 16633145 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine hydrogen bromide (HBr) at a mean daily dose of 19.8 mg (± 6.4 mg) for 12 weeks
Number of subjects: 36
Study 16633145 — intervention group
Group type: COMPARATOR
Intervention: Placebo at a mean daily dose of 21.8 mg (± 4.6 mg) for 12 weeks
Number of subjects: 36
Study 15253739 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (300 mg, intravenous sodium ascorbate)
Number of subjects: 60
Study 15253739 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 60
Study 11291823 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid formats (digits and letters)
Number of subjects: 85
Study 11291823 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedding both geographical and organizational information
Number of subjects: 85
Study 11291823 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedding both geographical information and organizational information
Number of subjects: 85
Study 9815661 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8282473 — intervention group
Group type: EXPERIMENTAL
Intervention: CBORT
Number of subjects: 463
Study 8282473 — intervention group
Group type: COMPARATOR
Intervention: GORS
Number of subjects: 463
Study 8282473 — intervention group
Group type: COMPARATOR
Intervention: CBORS
Number of subjects: 463
Study 2881320 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02 mcg/kg CCK‐8
Number of subjects: 30
Study 2881320 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04 mcg/kg CCK‐8
Number of subjects: 30
Study 2881320 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30
Study 31062131 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 10 mbar
Number of subjects: 33
Study 31062131 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 5 mbar
Number of subjects: 33
Study 31062131 — intervention group
Group type: COMPARATOR
Intervention: PEEP 0 mbar
Number of subjects: 33
Study 30407354 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuganjianpihuatanxingqi decoction (SD)
Number of subjects: 228
Study 30407354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study 27012938 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 simulation sessions over 1 year (experimental group)
Number of subjects: 48
Study 27012938 — intervention group
Group type: COMPARATOR
Intervention: 3 simulation sessions over 1 year (control group)
Number of subjects: 48
Study 27012938 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment of perceived impact of simulations on clinical practice
Number of subjects: 48
Study 27012938 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of post-traumatic stress disorder by self-assessment questionnaire on the 7th day and after 1 month
Number of subjects: 48
Study 25690866 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mediterranean-type diet with fat modification (canola oil, walnuts, walnut oil) and two portion-controlled sweet daily snacks for 12 weeks.
Number of subjects: 100
Study 25690866 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (no intervention).
Number of subjects: 100
Study 22652582 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7 (1.0 mL)
Number of subjects: 181
Study 22652582 — intervention group
Group type: COMPARATOR
Intervention: PPSV23
Number of subjects: 181
Study 20634898 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious conflict (weakly masked primes)
Number of subjects: 0
Study 20634898 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconscious conflict (strongly masked primes)
Number of subjects: 0
Study 20634898 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 18380559 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP + beta-TCP + GTR
Number of subjects: 28
Study 18380559 — intervention group
Group type: COMPARATOR
Intervention: beta-TCP + GTR
Number of subjects: 28
Study 16002808 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine supplementation (2.6 g choline/d)
Number of subjects: 26
Study 16002808 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine (1.5 g choline) on the first day of supplementation
Number of subjects: 26
Study 12208795 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/d for 12 weeks
Number of subjects: 50
Study 12208795 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term simvastatin treatment
Number of subjects: 50
Study 12208795 — intervention group
Group type: COMPARATOR
Intervention: High-fat meal and glucose alone
Number of subjects: 50
Study 12208795 — intervention group
Group type: COMPARATOR
Intervention: High-fat meal plus glucose
Number of subjects: 50
Study 10626570 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation with tablets, average dose 175 microg K-Iodide/day
Number of subjects: 100
Study 10626570 — intervention group
Group type: COMPARATOR
Intervention: Non-iodine-supplemented group
Number of subjects: 100
Study 10626570 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoker's newborns
Number of subjects: 100
Study 10626570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal TSH screening
Number of subjects: 100
Study 8554943 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancopride 10 mg
Number of subjects: 0
Study 8554943 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancopride 5 mg
Number of subjects: 0
Study 8554943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1782064 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of 20 mg/m2 per day on days 1‐5 and 22‐26 with irradiation on days 2, 5, 9, 16, 23 and 26
Number of subjects: 55
Study 1782064 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg cisplatin over 24 h commencing 1 h before each fraction of irradiation on days 1, 4, 8, 11, 15 and 18
Number of subjects: 55
Study 6119170 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide (30 mg t.d.s.)
Number of subjects: 63
Study 6119170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 6119170 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 63
Study 30117327 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 39
Study 30117327 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 39
Study 31567965 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared light-emitting diode (LED) treatment for bruxism
Number of subjects: 76
Study 31567965 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint treatment for bruxism
Number of subjects: 76
Study 31567965 — intervention group
Group type: COMPARATOR
Intervention: Control group (absence of bruxism)
Number of subjects: 76
Study 28608398 — intervention group
Group type: EXPERIMENTAL
Intervention: Biogran alone (Group 1)
Number of subjects: 30
Study 28608398 — intervention group
Group type: EXPERIMENTAL
Intervention: Biogran + autogenous bone graft (1:1) (Group 2)
Number of subjects: 30
Study 28608398 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone graft alone (Group 3)
Number of subjects: 30
Study 26528814 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation
Number of subjects: 0
Study 26528814 — intervention group
Group type: COMPARATOR
Intervention: Cathodal stimulation
Number of subjects: 0
Study 26528814 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 22431415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 79
Study 21909502 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral squamous cell carcinoma patients
Number of subjects: 31
Study 21909502 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative oral squamous cell carcinoma patients
Number of subjects: 31
Study 21909502 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 31
Study 21909502 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral squamous cell carcinoma patients (both groups)
Number of subjects: 31
Study 19678579 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 90
Study 19678579 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefalexin
Number of subjects: 90
Study 19678579 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment only
Number of subjects: 90
Study 17519147 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined contraceptive vaginal ring (CCVR)
Number of subjects: 0
Study 17519147 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptives (COCs)
Number of subjects: 0
Study 15553285 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond) with flowable composite (Filtek Flow)
Number of subjects: 46
Study 15553285 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond) without flowable composite
Number of subjects: 46
Study 15553285 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etch adhesive (Prime&Bond NT) with flowable composite (Filtek Flow)
Number of subjects: 46
Study 15553285 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etch adhesive (Prime&Bond NT) without flowable composite
Number of subjects: 46
Study 15553285 — intervention group
Group type: COMPARATOR
Intervention: Overall (both adhesives)
Number of subjects: 46
Study 11777512 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with detrusor instability
Number of subjects: 33
Study 11777512 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal urodynamic testing)
Number of subjects: 33
Study 9847040 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of high-pitched danger-signal tones
Number of subjects: 0
Study 9847040 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating tones throughout avoidance trials
Number of subjects: 0
Study 7792555 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral prosthetic implantation (MPI)
Number of subjects: 12
Study 7792555 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve replacement (MVR)
Number of subjects: 12
Study 2666532 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral piroxicam (17-day course)
Number of subjects: 178
Study 2666532 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroid CME treatment
Number of subjects: 178
Study 2666532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 178
Study 803203 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 0
Study 803203 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study 30370681 — intervention group
Group type: EXPERIMENTAL
Intervention: Short intervention targeting psychosomatic care (home visit by a doctor trained in psychosomatic medicine)
Number of subjects: 175
Study 30370681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 175
Study 28502503 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vitamin D (50,000 IU every 2 weeks) + omega-3 fatty acids (1000 mg twice a day)
Number of subjects: 140
Study 26134988 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve BR03 and B. breve B632 (2 × 10^9 colony-forming units)
Number of subjects: 49
Study 26134988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 23375799 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Aerobics Group (AAG)
Number of subjects: 82
Study 23375799 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 82
Study 21641021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS applied to the right superior temporal gyrus
Number of subjects: 3
Study 21641021 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied to the left superior temporal gyrus
Number of subjects: 3
Study 21641021 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 3